Naloxone

CAT:
804-HY-17417A-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Naloxone - image 1

Naloxone

  • Description :

    Naloxone is an antagonist of Opioid receptor. Naloxone alleviates opioid-overdose-induced respiratory depression. Naloxone may cause pulmonary edema and cardiac arrhythmias[1].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302
  • Target :

    Opioid Receptor
  • Type :

    Reference compound
  • Related Pathways :

    GPCR/G Protein; Neuronal Signaling
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Neurological Disease; Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/naloxone.html
  • Purity :

    99.71
  • Solubility :

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles :

    OC1=C(O2)C([C@]([C@]2([H])C(CC3)=O)(CCN4CC=C)[C@]3(O)[C@H]4C5)=C5C=C1
  • Molecular Formula :

    C19H21NO4
  • Molecular Weight :

    327.37
  • Precautions :

    H302
  • References & Citations :

    [1]McIntosh TK, et al. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat. J Neurotrau|[2]Sun L, et al. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. Eur J Pain. 2017 May;21 (5) :804-814.|[3]Izquierdo I, et al. Effect of ACTH, epinephrine, beta-endorphin, naloxone, and of the combination of naloxone or beta-endorphinwith ACTH or epinephrine on memory consolidation. Psychoneuroendocrinology. 1983;8 (1) :81-7.|[4]Soteropoulos GC, et al. Neuromuscular effects of morphine and naloxone. J Pharmacol Exp Ther. 1973 Jan;184 (1) :136-42.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    4°C (Powder, protect from light, stored under nitrogen)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • Citation 01 :

    Nature. 2025 Dec;648 (8094) :755-763.|Br J Pharmacol. 2025 Jul 21.|Cell Rep. 2020 Mar 17;30 (11) :3625-3631.e6. |Eur J Pain. 2017 May;21 (5) :804-814.|Nat Commun. 2025 Aug 1;16 (1) :7074.
  • CAS Number :

    [465-65-6]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide